FCF Biotech Venture Capital Monitor – USA 12/2020 published

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 12/2020”.

The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector.

As of the end of December 2020, we identify the following current VC trends in the US-Biotech sector:

  • In December 2020 the investment volume in the US-Biotech sector amounted to USD 1,835m
  • In 2020, overall Biotech funding in the USA reached USD 22,405m (+65% compared to 2019)
  • Top 5 deals in 2020 exceed USD 300m each, largest transaction amounted to USD 755m in National Resilience, Inc.

To access the full report, please click here.

By Dr. Mathias Schott, Sebastian Sommer and Alexander Kuhn